Stocktwits Top 25 – Week 29 📈

ST Top 25 S&P 500

The ST Top 25 S&P 500 List broke its three-week losing streak.

20 of 25 names closed positive.

Oil stocks got no love in Week 29. $DVN, $MRO, $EOG, and $FANG all traded lower. 

$HCA gained 13.35% and entered the list as a Freshman. The health care company is now ranked #16 and a Winner below.

Four Freshmen debuted on the list. They are $HCA, $IPG, $NVDA, and $RHI.

The Stocktwits Top 25 S&P 500 Momentum Meter added 3.66% and the S&P 500 gained 1.96%. The 1.7% differential in favor of the top stoks shows the leading stocks outperformed by a fair amount.

ST Top 25 Nasdaq 100

The ST Top 25 N100 was the greenest of all lists.

25/25 names closed positive. ✅

KLA Corporation climbed 9.4% and was the list’s biggest gainer. $KLAC is up 23.9% YTD.

$AMAT reclaimed the top ranking on the list from $GOOG. We’ve got ourselves a rivalry now. 😈

One Freshman made the list. It is KLA Corporation. 

The ST Top 25 Nasdaq 100 Momentum Meter ripped 5.14% in Week 29 while the full Nasdaq 100 gained 2.93%. The 2.21% difference shows the full index was weaker than the top stocks by a decent amount.

ST Top 25 Russell 2000

The ST Top 25 R2K List pieced itself back together in Week 29.

17 of 25 names traded higher. 

Cassava Sciences soared 54% and stole the top spot on the list from AMC Entertainment. It’s the Top Dawg below.

$AMEH ascended 45.75%, $ORMP increased 17%, and $BTU bounced 25.5%. 

Three new stocks appeared on the ST Top 25 Russell 2000 list. The tickers are $VRTV, $DDS, and $HOV.

The ST Top 25 R2K Momentum Meter increased 8.80% and the Russell 2000 index rallied 2.15%. The 6.65% differential suggests top stocks were stronger than the full index by a large amount.

ST Top 25 TOP DAWG OF THE WEEK 🐶

The ST Top 25 Top Dawg for Week 29, 2021 is #1 R2K – Cassava Sciences. 

Cassava Sciences soared 54% in week 29 and took over the top spot on the ST Top 25 R2K List. 

The biotech company gained a blistering 29.5% on Wednesday after announcing an impending presentation at the AAIC’s annual conference. 

The company has been developing a drug for Alzheimer’s disease. New results from a phase 2 study with Simufilam, a possible first-in-class stabilizer of a structural protein called filamin A, will be presented on July 29, 2021.

$SAVA is up 1,709% YTD and closed at all-time weekly highs.

The Winners📈

△ #16 S&P 500 – HCA Healthcare hopped 13.35% in Week 29 and was the ST Top 25 S&P 500 List’s biggest winner. The health care company is now ranked #16 as a Freshman.

$HCA posted Q2 results before the bell Tuesday that were above analyst expectations. HCA also dramatically boosted full-year projections, citing ongoing increases in operations and emergency room visits.

Here are the stats:

EPS: $4.36 vs $3.16 est
Revenue: $14.4B, +30% YoY

$HCA is up 51% YTD.

△ #21 N100 – KLA Corporation climbed back onto the ST Top 25 N100 List thanks to a 9.4% weekly gain. The semiconductor was the only Freshman on the list.

$KLAC closed green 4/5 sessions this week and made back all of the losses from weeks 26-28.

Here’s the weekly chart:

KLA Corp is set to report earnings next Thursday, July 29.

△ #3 R2K- Apollo Medical Holdings ascended into space like an Apollo rocket. The medical company improved two spots on the ST Top 25 R2K List. 

On Monday, Apollo Medical Holdings announced that its affiliate (AP-AMH 2 Medical Corporation) entered into a definitive agreement to acquire 80 percent of Access Primary Care Medical Group.

Over 120 APCMG primary and specialty care providers serving roughly 1,000 Medicare Advantage enrollees will benefit from ApolloMed’s technology and operations platform.

Kenneth Sim, Co-Chief Executive Officer of ApolloMed said: 

“We are thrilled with the expansion of our existing partnership with APCMG, an impressive group of primary care physicians that is committed to delivering affordable, high-quality value-based care to local communities. APCMG will provide ApolloMed with a strong foothold in the Bay Area with the opportunity to expand from San Francisco down the Peninsula.”

$AMEH is up 517.6% YTD and sits at all-time highs.

The Sinners📉

▼ #20 S&P 500 – EOG Resources descended 1.9% in Week 29 and worsened its ranking on the ST Top 25 S&P 500 List by 2x. $EOG is now ranked #20. 

$EOG sank 4.8% on Monday after crude oil traded 7.6% lower. This is because OPEC+ decided on July 18 to progressively lift the remaining output limits that began last year. 

Here’s the daily chart:

$EOG is up 48.4% YTD.

▼ #5 R2K – Atossa Therapeutics traded lower for the fourth straight week. The company switched spots with Winner $AMEH on the ST Top 25 R2K List. $ATOS is now ranked #5. 

The stock opened 8% lower Monday morning before closing the day down 13%. $ATOS chopped around the rest to finish the week without making any real progress. 

Is Atossa Therapeutics toast or is there more room for this to run?? Place your bets…

$ATOS is still up 340% YTD.